[…]
Read More… from The Case for Chromogenic Agar in the Age of MALDI-TOF MS
The Case for Chromogenic Agar in the Age of MALDI-TOF MS
Category: MDC Blog
Risk Management Guidance for Medical Devices Incorporating Machine Learning (ML) or Artificial Intelligence (AI)
From Concept to Market: How the FDA’s Breakthrough Device Designation Works
The Value of Internal Quality Audits
Key Points from the Nov 2024 FDA IVD Roundtable
QSR to QMSR, FDA’s New Standard —By Incorporation: ISO 13485
Enhancing Sepsis Care: Expediting Blood Culture Processing for Rapid AST
Key IVD-wise Takeaways from ADLM 2024
PCCP: A New Option for Changes to Your 510(k)
FDA Updates MDUFA V User Fees for FY 2025
